AstraZeneca PLC (AZNCF) Financials

AZNCF Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 114.1 billion 65.4 billion
Sept. 30, 2025 114.5 billion 68.5 billion
June 30, 2025 112.4 billion 67.6 billion
March 31, 2025 106.3 billion 65.2 billion

AZNCF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 1.1 billion ?
Sept. 30, 2025 4.4 billion ?
June 30, 2025 1.5 billion ?
March 31, 2025 3.4 billion ?

AZNCF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 2.3 billion
Sept. 30, 2025 2.5 billion
June 30, 2025 3.1 billion
March 31, 2025 3.0 billion

AZNCF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 - - 1.8 billion
Sept. 30, 2025 8.2 billion 26.1 billion 1.8 billion
June 30, 2025 7.1 billion 26.0 billion 1.6 billion
March 31, 2025 5.4 billion 27.9 billion 1.6 billion

AZNCF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 1.6 billion
Sept. 30, 2025 1.6 billion
June 30, 2025 1.6 billion
March 31, 2025 1.6 billion

AZNCF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 1.3 billion 3.9 billion 5.6 billion -
Sept. 30, 2025 686.0 million 3.7 billion 5.1 billion 148.0 million
June 30, 2025 1.9 billion 3.5 billion 5.0 billion 143.0 million
March 31, 2025 440.0 million 3.2 billion 4.6 billion 132.0 million

AZNCF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 15.5 billion 3.1 billion
Sept. 30, 2025 15.2 billion 2.9 billion
June 30, 2025 14.5 billion 2.5 billion
March 31, 2025 13.6 billion 2.2 billion

AZNCF

Price: $187.45

52 week price:
122.26
209.48

Dividend Yield: 1.56%

5-year range yield:
1.56%
5.92%

Forward Dividend Yield: 4.63%

Payout Ratio: 47.51%

Payout Ratio Range:
-85.64%
786.97%

Dividend Per Share: 8.68 USD

Earnings Per Share: 6.03 USD

P/E Ratio: 33.46

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United Kingdom

Market Capitalization: 312.8 billion

Average Dividend Frequency: 3

Years Paying Dividends: 18

DGR3: 30.00%

DGR5: 19.57%

DGR10: 9.73%

Links: